Cardiovascular Diseases Clinical Trial
Official title:
Musical Heart Rhythm Regulation: The MUSIC-HR Study
The idea that music has an effect on heart rate and blood pressure has existed for some time.
In 1918, Hyde and Scalapino [1] reported that minor tones increased pulse rate and lowered
blood pressure, whereas "stirring" music increased both blood pressure and heart rate. In the
management of many cardiovascular disorders heart rate control is paramount. Furthermore,
many cardiovascular investigations (e.g. Cardiac CT) require adequate heart rate control in
order to achieve diagnostic images and therefore results. Whilst pharmacologic therapy is
available and remains the main strategy for heart rate control, this is not always without
consequences. Side effect profiles, patient intolerance and also variable efficacy are
limiting factors for pharmacological therapy. Alternative strategies to achieve adequate
heart rate control are therefore needed.
The aim of this study is to explore the potential use of music to control heart rates and
other physiological parameters such as respiratory rate and blood pressure. The central study
team hypothesize that by changing the tempo of the music they will be able to influence the
natural variations in heart rate.
1. Hyde IM, Scalapino W. The influence of music upon electrocardiograms and blood pressure.
Am J Physiol.1918Íž46:35-38.
This is a single-arm non-randomized pilot study. Staff at Chelsea and Westminster NHS
Foundation Trust will be recruited via the placement of posters in staff only areas such as
staff rooms and via the daily communications that the Trust use. Those who meet all of the
inclusion criteria and none of the exclusion criteria will be approached for participation in
the study. The participants will be asked to listen to a series of musical genres, selected
in random order, whilst lying on a standard hospital bed for comfort. This will take place in
a private clinical room to minimise disturbance and any variation in heart rate caused by
external stressors. The participants will have an ECG recording performed by attachment of
adhesive surface lead electrodes to the chest and arms. This will be continuous throughout
the protocol. They will also have a continuous non-invasive blood pressure recording using
equipment that is in routine clinical practice (Finapress BP) and respiration monitored via a
respiration belt. They will also be asked to wear a small lightweight sensor that gives
readings of heart rate and blood pressure at 2 minute intervals.
After a period of approximately 10 minutes of ECG recording without music (control period), a
series of pieces of music will be played whilst the ECG recordings continue. Each piece of
music will last for no more than 5 minutes, 3 will be selected by the investigators and one
will be pre-chosen by the participant prior to their attendance. The order in which these
pieces will be played will be chosen at random. There will be a 3 minute recovery time in
between each piece of music. The same pieces of music will then be played back to the
participant but this time the music will subtly change tempo in reaction to the patient's
heart rate. This is achieved by the ECG feeding data into the computer playing the music,
whereupon the data is processed by Max MSP software and used to control the playback speed in
Ableton Live. The algorithm for change is a linear one: the higher a patient's heart rate is
in relation to a desired bpm target, the more the music will slow down. (There will be a
limit to the extent of the tempo adjustment, in order to prevent any noticeable distortion to
the music.)
The tempo of the music is controlled by computer. The ECG recording will feed into the
computer where the software alters the tempo of the music based on the real-time heart rate
feedback. The hypothesis is that by altering the tempo of the music the investigators will
see changes in the heart rate of the participant. These changes will then feedback to the
software which will continue to alter the tempo accordingly with the aim to achieve a degree
of heart rate control and see less heart rate variation and less high heart rates. It should
take around one hour to complete all the study procedures.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|